iCET, an initiative to develop critical and emerging technologies, has just brought biotech & other digital infra within its ambit. Biocon founder was speaking at Global Technology Summit.
Kiran Mazumdar-Shaw was appointed to the Infosys' Board in 2014 & became Lead Independent Director in 2018. D Sundaram wll succeed her as the Lead Independent Director from Thursday.
The investigation is based on nearly 12 million documents obtained by the International Consortium and Investigative Journalists. The list names several prominent Indians and world leaders.
Under the deal, Biocon Biologics Ltd (BBL) will offer approximately 15% stake to Serum Institute Life Sciences at a post-money valuation of about Rs 35,000 crore.
Speaking to students of Delhi's government schools, Shaw talked about her journey as a businesswoman and said that one must always think about giving back to society.
I was expecting the infection to be mild and short-lived. My Covid-19 experience has matched these expectations and I hope that it allays the fear of the virus.
Biocon co-founder Kiran Mazumdar-Shaw also questioned the launch of a vaccine prior to completion of Phase 3 trials, saying if it's acceptable to Russia, so be it.
Meghnad’s interest went much beyond economics and politics. This is reflected in his writing, particularly after his retirement as a full-time LSE professor in 2003.
In the latest budget, the FDI limit was increased to 100 percent, but most foreign companies are not buying such large stakes in the Indian insurance sector.
As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.
COMMENTS